DOVER, Del. - TelAve -- ReproTech LLC, a leading provider of reproductive cryostorage and cryostorage technology solutions, is pleased to announce a significant investment in Matcher Technologies Ltd, a recognized innovator in the fertility industry known for its flagship electronic witnessing product, IMT Matcher.

This strategic investment strengthens ReproTech's leadership in cryostorage by enhancing its existing traceability solutions. The integration of Matcher's expertise and technology with ReproTech's existing suite of cryostorage and safety focused products marks a major step towards the first comprehensive platform for patients and clinics to digitally document every step of the IVF process while providing the safest storage solutions on the market.

"We are thrilled to partner with Matcher to continue our combined journey of providing the highest quality, safest and most compliant products for our clinic partners," said Brad Senstra, ReproTech CEO. "Their team, technology, mission and values align perfectly with our commitment to exceptional service, advanced technologies, and stringent compliance standards."

More on TelAve News

• $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
• $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
• Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
• Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
• Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT

Matcher Technologies Ltd, founded in 2005, has built a strong reputation for the capability and quality of its product, continual innovation, and excellent customer service. Following the investment, Matcher's operations will continue from its U.K. headquarters uninterrupted for end users and the existing distributor network.

"ReproTech's reputation as a trusted storage solutions partner—with 35 years of experience—and their dedication to advancing traceability in fertility care make them an ideal partner." said George Heywood, CEO of Matcher Technologies Ltd. "Together, we can drive innovation and enhance our service offerings in both domestic and international markets."

ReproTech was advised by Shoosmiths LLP, BDO LLP, and Armstrong Teasdale LLP. Matcher Technologies Ltd was supported by Clearwater International, Brabners LLP, and Claritas Tax.

For more information, visit the Reprotech or IMT Matcher website.

About ReproTech LLC

ReproTech is a Delaware-based provider of cryostorage technology solutions, off-site storage and logistics services. The company partners with fertility clinics, hospital systems, donor banks, and andrology laboratories across North America to offer secure, state-of-the-art storage for sperm, oocytes, embryos, stem cells, oncofertility specific tissues, and other reproductive tissues - ensuring patients have future options for family formation. ReproTech distinguishes itself through exceptional service, advanced technologies, and stringent compliance standards.  Learn more at www.ReproTech.com.

More on TelAve News

• Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings
• AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
• The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
• Ace8 Launches Cutting-Edge Observability Service to Empower Modern IT Operations
• AceMQ Unveils Advanced Containerization Solutions to Accelerate Digital Transformation

About Matcher Technologies Ltd

Matcher Technologies Ltd. is a UK based, global leader in fertility technology, renowned for developing IMT Matcher - the world's first electronic witnessing system - over 20 years ago. Over the past two decades, the company has played a pivotal role in shaping industry standards and educating the market. Built on insights from hundreds of fertility center customers worldwide, IMT Matcher has become the highest quality witnessing and traceability system of choice for clinics across the globe. With a deep commitment to innovation, Matcher has continuously invested in product development, driven by a highly skilled, multi-disciplinary, global team. The company's commitment to quality is underscored by longstanding relationships with global players and a trusted reputation for delivering excellent customer service in pursuit of protecting patients, fertility centers and donor banks from the risks of error in IVF. Learn more at www.imtmatcher.com.